Structure

Physi-Chem Properties

Molecular Weight:  480.16
Volume:  447.092
LogP:  0.39
LogD:  0.244
LogS:  -2.442
# Rotatable Bonds:  7
TPSA:  170.83
# H-Bond Aceptor:  11
# H-Bond Donor:  6
# Rings:  5
# Heavy Atoms:  11

MedChem Properties

QED Drug-Likeness Score:  0.205
Synthetic Accessibility Score:  5.163
Fsp3:  0.565
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -6.104
MDCK Permeability:  6.575594306923449e-05
Pgp-inhibitor:  0.001
Pgp-substrate:  0.543
Human Intestinal Absorption (HIA):  0.889
20% Bioavailability (F20%):  0.566
30% Bioavailability (F30%):  0.998

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.16
Plasma Protein Binding (PPB):  60.1287727355957%
Volume Distribution (VD):  0.406
Pgp-substrate:  33.713218688964844%

ADMET: Metabolism

CYP1A2-inhibitor:  0.03
CYP1A2-substrate:  0.021
CYP2C19-inhibitor:  0.016
CYP2C19-substrate:  0.126
CYP2C9-inhibitor:  0.005
CYP2C9-substrate:  0.034
CYP2D6-inhibitor:  0.004
CYP2D6-substrate:  0.114
CYP3A4-inhibitor:  0.053
CYP3A4-substrate:  0.113

ADMET: Excretion

Clearance (CL):  1.781
Half-life (T1/2):  0.885

ADMET: Toxicity

hERG Blockers:  0.183
Human Hepatotoxicity (H-HT):  0.335
Drug-inuced Liver Injury (DILI):  0.063
AMES Toxicity:  0.07
Rat Oral Acute Toxicity:  0.141
Maximum Recommended Daily Dose:  0.021
Skin Sensitization:  0.31
Carcinogencity:  0.945
Eye Corrosion:  0.003
Eye Irritation:  0.031
Respiratory Toxicity:  0.958

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC475824

Natural Product ID:  NPC475824
Common Name*:   (-)-Specioside
IUPAC Name:   (2S,3R,4S,5S,6R)-2-[[(1aR,1bS,2S,5aR,6S,6aS)-1a-(hydroxymethyl)-6-[(E)-2-(4-hydroxyphenyl)ethenoxy]-2,5a,6,6a-tetrahydro-1bH-oxireno[5,6]cyclopenta[1,3-c]pyran-2-yl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol
Synonyms:   (-)-Specioside
Standard InCHIKey:  AWKRVVGAVDYMNU-XKVKTCGNSA-N
Standard InCHI:  InChI=1S/C23H28O11/c24-9-14-16(27)17(28)18(29)22(32-14)33-21-15-13(6-8-31-21)19(20-23(15,10-25)34-20)30-7-5-11-1-3-12(26)4-2-11/h1-8,13-22,24-29H,9-10H2/b7-5+/t13-,14-,15-,16-,17+,18-,19+,20+,21+,22+,23+/m1/s1
SMILES:  C1=COC(C2C1C(C3C2(O3)CO)OC=CC4=CC=C(C=C4)O)OC5C(C(C(C(O5)CO)O)O)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL516849
PubChem CID:   44566579
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0004603] Organic oxygen compounds
      • [CHEMONTID:0000323] Organooxygen compounds
        • [CHEMONTID:0000011] Carbohydrates and carbohydrate conjugates
          • [CHEMONTID:0002105] Glycosyl compounds
            • [CHEMONTID:0002207] O-glycosyl compounds

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO10745 Stereospermum personatum Species Bignoniaceae Eukaryota n.a. n.a. n.a. PMID[16309309]
NPO10745 Stereospermum personatum Species Bignoniaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO10745 Stereospermum personatum Species Bignoniaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. SC50 = 160.85 uM PMID[460119]
NPT967 Individual Protein Xanthine dehydrogenase Homo sapiens IC50 = 79880.0 nM PMID[460119]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC475824 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9323 High Similarity NPC46644
0.903 High Similarity NPC49597
0.8986 High Similarity NPC474234
0.8921 High Similarity NPC18789
0.8841 High Similarity NPC478240
0.8705 High Similarity NPC184464
0.8705 High Similarity NPC251062
0.8633 High Similarity NPC237872
0.8633 High Similarity NPC88754
0.8633 High Similarity NPC302286
0.8633 High Similarity NPC116104
0.8633 High Similarity NPC263397
0.8623 High Similarity NPC7518
0.8623 High Similarity NPC154262
0.8623 High Similarity NPC159387
0.8623 High Similarity NPC137501
0.8611 High Similarity NPC194705
0.8552 High Similarity NPC89693
0.8552 High Similarity NPC229548
0.8552 High Similarity NPC478241
0.8516 High Similarity NPC476445
0.8516 High Similarity NPC469548
0.8516 High Similarity NPC476448
0.8507 High Similarity NPC254819
0.85 High Similarity NPC186296
0.8462 Intermediate Similarity NPC232454
0.8462 Intermediate Similarity NPC178449
0.8462 Intermediate Similarity NPC470907
0.8451 Intermediate Similarity NPC37838
0.845 Intermediate Similarity NPC469686
0.8438 Intermediate Similarity NPC469702
0.8438 Intermediate Similarity NPC282409
0.8413 Intermediate Similarity NPC148055
0.8403 Intermediate Similarity NPC478236
0.84 Intermediate Similarity NPC157338
0.8385 Intermediate Similarity NPC471067
0.8378 Intermediate Similarity NPC475378
0.8372 Intermediate Similarity NPC469703
0.8372 Intermediate Similarity NPC201402
0.8372 Intermediate Similarity NPC469704
0.8372 Intermediate Similarity NPC160854
0.8346 Intermediate Similarity NPC175333
0.8345 Intermediate Similarity NPC117346
0.8345 Intermediate Similarity NPC240592
0.8345 Intermediate Similarity NPC147224
0.8333 Intermediate Similarity NPC90318
0.8308 Intermediate Similarity NPC55608
0.8299 Intermediate Similarity NPC229354
0.8288 Intermediate Similarity NPC478249
0.8288 Intermediate Similarity NPC269914
0.8276 Intermediate Similarity NPC96599
0.8276 Intermediate Similarity NPC478234
0.8268 Intermediate Similarity NPC175771
0.8255 Intermediate Similarity NPC478248
0.8254 Intermediate Similarity NPC313193
0.8243 Intermediate Similarity NPC478232
0.8212 Intermediate Similarity NPC478265
0.8212 Intermediate Similarity NPC138993
0.8209 Intermediate Similarity NPC469687
0.8207 Intermediate Similarity NPC308178
0.8182 Intermediate Similarity NPC202391
0.8182 Intermediate Similarity NPC296659
0.8168 Intermediate Similarity NPC266045
0.8163 Intermediate Similarity NPC289021
0.8163 Intermediate Similarity NPC158546
0.8134 Intermediate Similarity NPC267733
0.8134 Intermediate Similarity NPC276047
0.8085 Intermediate Similarity NPC31745
0.8085 Intermediate Similarity NPC220936
0.8074 Intermediate Similarity NPC108659
0.8074 Intermediate Similarity NPC264900
0.8074 Intermediate Similarity NPC231607
0.8074 Intermediate Similarity NPC79715
0.8015 Intermediate Similarity NPC148982
0.8 Intermediate Similarity NPC252114
0.8 Intermediate Similarity NPC94179
0.7987 Intermediate Similarity NPC478235
0.7986 Intermediate Similarity NPC6836
0.7985 Intermediate Similarity NPC287429
0.7985 Intermediate Similarity NPC145287
0.7971 Intermediate Similarity NPC478255
0.797 Intermediate Similarity NPC52097
0.797 Intermediate Similarity NPC476142
0.7956 Intermediate Similarity NPC184092
0.7956 Intermediate Similarity NPC253595
0.7955 Intermediate Similarity NPC469412
0.7955 Intermediate Similarity NPC269242
0.7955 Intermediate Similarity NPC198734
0.7949 Intermediate Similarity NPC130730
0.7949 Intermediate Similarity NPC301910
0.7947 Intermediate Similarity NPC475484
0.7943 Intermediate Similarity NPC472132
0.7941 Intermediate Similarity NPC106677
0.7941 Intermediate Similarity NPC288416
0.7931 Intermediate Similarity NPC473281
0.7931 Intermediate Similarity NPC77922
0.7929 Intermediate Similarity NPC470881
0.7929 Intermediate Similarity NPC169398
0.7926 Intermediate Similarity NPC470510
0.7926 Intermediate Similarity NPC126991
0.7926 Intermediate Similarity NPC83218
0.7919 Intermediate Similarity NPC475379
0.7914 Intermediate Similarity NPC252833
0.7902 Intermediate Similarity NPC164743
0.7895 Intermediate Similarity NPC11724
0.7895 Intermediate Similarity NPC478266
0.7887 Intermediate Similarity NPC304152
0.7883 Intermediate Similarity NPC225307
0.7877 Intermediate Similarity NPC475528
0.7872 Intermediate Similarity NPC79957
0.7871 Intermediate Similarity NPC206815
0.7868 Intermediate Similarity NPC471157
0.7862 Intermediate Similarity NPC293154
0.7857 Intermediate Similarity NPC164172
0.7857 Intermediate Similarity NPC25821
0.7847 Intermediate Similarity NPC472711
0.7842 Intermediate Similarity NPC248307
0.7842 Intermediate Similarity NPC65942
0.7826 Intermediate Similarity NPC307110
0.7826 Intermediate Similarity NPC469549
0.7823 Intermediate Similarity NPC143246
0.7823 Intermediate Similarity NPC474268
0.7823 Intermediate Similarity NPC119773
0.7823 Intermediate Similarity NPC475539
0.782 Intermediate Similarity NPC476872
0.781 Intermediate Similarity NPC471882
0.781 Intermediate Similarity NPC156692
0.781 Intermediate Similarity NPC35288
0.781 Intermediate Similarity NPC45224
0.781 Intermediate Similarity NPC471881
0.781 Intermediate Similarity NPC173150
0.7808 Intermediate Similarity NPC470235
0.7808 Intermediate Similarity NPC84181
0.7808 Intermediate Similarity NPC283995
0.7808 Intermediate Similarity NPC194938
0.7808 Intermediate Similarity NPC63304
0.7808 Intermediate Similarity NPC129417
0.7801 Intermediate Similarity NPC35731
0.7793 Intermediate Similarity NPC472353
0.7786 Intermediate Similarity NPC303422
0.7786 Intermediate Similarity NPC254275
0.7786 Intermediate Similarity NPC26080
0.7786 Intermediate Similarity NPC471066
0.7786 Intermediate Similarity NPC85799
0.7786 Intermediate Similarity NPC471095
0.7786 Intermediate Similarity NPC473924
0.7786 Intermediate Similarity NPC165686
0.7778 Intermediate Similarity NPC212176
0.777 Intermediate Similarity NPC470122
0.777 Intermediate Similarity NPC17968
0.777 Intermediate Similarity NPC469705
0.7762 Intermediate Similarity NPC469364
0.7762 Intermediate Similarity NPC65262
0.7762 Intermediate Similarity NPC101686
0.7756 Intermediate Similarity NPC476011
0.7754 Intermediate Similarity NPC158673
0.7746 Intermediate Similarity NPC476870
0.7744 Intermediate Similarity NPC469708
0.7744 Intermediate Similarity NPC60589
0.774 Intermediate Similarity NPC46092
0.774 Intermediate Similarity NPC475213
0.774 Intermediate Similarity NPC477898
0.774 Intermediate Similarity NPC470950
0.774 Intermediate Similarity NPC152796
0.774 Intermediate Similarity NPC185307
0.7737 Intermediate Similarity NPC61181
0.7733 Intermediate Similarity NPC35097
0.773 Intermediate Similarity NPC254398
0.773 Intermediate Similarity NPC115022
0.773 Intermediate Similarity NPC294166
0.7718 Intermediate Similarity NPC120728
0.7714 Intermediate Similarity NPC476407
0.7714 Intermediate Similarity NPC225384
0.7714 Intermediate Similarity NPC46137
0.7714 Intermediate Similarity NPC246869
0.7714 Intermediate Similarity NPC219677
0.7714 Intermediate Similarity NPC121376
0.7714 Intermediate Similarity NPC138777
0.7714 Intermediate Similarity NPC9912
0.7714 Intermediate Similarity NPC235294
0.771 Intermediate Similarity NPC473556
0.771 Intermediate Similarity NPC301651
0.7708 Intermediate Similarity NPC321638
0.7708 Intermediate Similarity NPC328273
0.7708 Intermediate Similarity NPC171134
0.7708 Intermediate Similarity NPC321184
0.7708 Intermediate Similarity NPC156376
0.7703 Intermediate Similarity NPC112861
0.7703 Intermediate Similarity NPC473147
0.7698 Intermediate Similarity NPC248355
0.7698 Intermediate Similarity NPC477294
0.7698 Intermediate Similarity NPC229784
0.7698 Intermediate Similarity NPC477293
0.7698 Intermediate Similarity NPC295970
0.7698 Intermediate Similarity NPC166040
0.7692 Intermediate Similarity NPC177035
0.7692 Intermediate Similarity NPC199459
0.7692 Intermediate Similarity NPC52277
0.7687 Intermediate Similarity NPC96447
0.7681 Intermediate Similarity NPC103533

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC475824 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.7702 Intermediate Similarity NPD7685 Pre-registration
0.7664 Intermediate Similarity NPD3094 Phase 2
0.763 Intermediate Similarity NPD1091 Approved
0.7466 Intermediate Similarity NPD7266 Discontinued
0.7372 Intermediate Similarity NPD3092 Approved
0.7183 Intermediate Similarity NPD2861 Phase 2
0.7097 Intermediate Similarity NPD1653 Approved
0.708 Intermediate Similarity NPD3091 Approved
0.6993 Remote Similarity NPD5058 Phase 3
0.6978 Remote Similarity NPD5126 Approved
0.6978 Remote Similarity NPD5125 Phase 3
0.6959 Remote Similarity NPD6653 Approved
0.6892 Remote Similarity NPD5735 Approved
0.6879 Remote Similarity NPD3705 Approved
0.6857 Remote Similarity NPD3095 Discontinued
0.6852 Remote Similarity NPD4381 Clinical (unspecified phase)
0.6849 Remote Similarity NPD3027 Phase 3
0.6828 Remote Similarity NPD5736 Approved
0.6824 Remote Similarity NPD3619 Clinical (unspecified phase)
0.6824 Remote Similarity NPD3620 Phase 2
0.6824 Remote Similarity NPD1613 Approved
0.6824 Remote Similarity NPD1612 Clinical (unspecified phase)
0.6797 Remote Similarity NPD6674 Discontinued
0.6786 Remote Similarity NPD1357 Approved
0.6781 Remote Similarity NPD4908 Phase 1
0.6776 Remote Similarity NPD5763 Approved
0.6776 Remote Similarity NPD5762 Approved
0.677 Remote Similarity NPD8455 Phase 2
0.6761 Remote Similarity NPD1610 Phase 2
0.6744 Remote Similarity NPD3020 Approved
0.6739 Remote Similarity NPD7157 Approved
0.6738 Remote Similarity NPD4059 Approved
0.6714 Remote Similarity NPD7741 Discontinued
0.671 Remote Similarity NPD6190 Approved
0.6689 Remote Similarity NPD4978 Clinical (unspecified phase)
0.6689 Remote Similarity NPD4907 Clinical (unspecified phase)
0.6667 Remote Similarity NPD6006 Clinical (unspecified phase)
0.6667 Remote Similarity NPD3021 Approved
0.6667 Remote Similarity NPD6002 Phase 3
0.6667 Remote Similarity NPD6003 Clinical (unspecified phase)
0.6667 Remote Similarity NPD6005 Phase 3
0.6667 Remote Similarity NPD6004 Phase 3
0.6667 Remote Similarity NPD3022 Approved
0.6645 Remote Similarity NPD5960 Phase 3
0.6645 Remote Similarity NPD5588 Approved
0.6644 Remote Similarity NPD6663 Approved
0.6644 Remote Similarity NPD6007 Clinical (unspecified phase)
0.6642 Remote Similarity NPD7843 Approved
0.6627 Remote Similarity NPD7199 Phase 2
0.6627 Remote Similarity NPD7228 Approved
0.6606 Remote Similarity NPD6234 Discontinued
0.6605 Remote Similarity NPD37 Approved
0.66 Remote Similarity NPD4140 Approved
0.6596 Remote Similarity NPD1548 Phase 1
0.6593 Remote Similarity NPD2684 Approved
0.6585 Remote Similarity NPD4967 Phase 2
0.6585 Remote Similarity NPD4966 Approved
0.6585 Remote Similarity NPD4965 Approved
0.6579 Remote Similarity NPD4538 Approved
0.6579 Remote Similarity NPD4536 Approved
0.6579 Remote Similarity NPD7097 Phase 1
0.6579 Remote Similarity NPD4537 Clinical (unspecified phase)
0.6575 Remote Similarity NPD6362 Approved
0.6562 Remote Similarity NPD2933 Approved
0.6562 Remote Similarity NPD2934 Approved
0.6554 Remote Similarity NPD1529 Clinical (unspecified phase)
0.6531 Remote Similarity NPD5647 Approved
0.6531 Remote Similarity NPD4624 Approved
0.6529 Remote Similarity NPD3818 Discontinued
0.6519 Remote Similarity NPD290 Approved
0.6513 Remote Similarity NPD6353 Approved
0.6512 Remote Similarity NPD2860 Approved
0.6512 Remote Similarity NPD2859 Approved
0.6507 Remote Similarity NPD8651 Approved
0.6503 Remote Similarity NPD5238 Clinical (unspecified phase)
0.6491 Remote Similarity NPD7054 Approved
0.6491 Remote Similarity NPD7804 Clinical (unspecified phase)
0.6486 Remote Similarity NPD1530 Clinical (unspecified phase)
0.6481 Remote Similarity NPD4380 Phase 2
0.6474 Remote Similarity NPD1652 Phase 2
0.6474 Remote Similarity NPD5698 Clinical (unspecified phase)
0.6467 Remote Similarity NPD6410 Clinical (unspecified phase)
0.6466 Remote Similarity NPD5738 Clinical (unspecified phase)
0.6453 Remote Similarity NPD7472 Approved
0.645 Remote Similarity NPD7184 Clinical (unspecified phase)
0.6449 Remote Similarity NPD969 Suspended
0.6447 Remote Similarity NPD5124 Phase 1
0.6447 Remote Similarity NPD6355 Discontinued
0.6447 Remote Similarity NPD5123 Clinical (unspecified phase)
0.6444 Remote Similarity NPD6685 Approved
0.6439 Remote Similarity NPD1242 Phase 1
0.6438 Remote Similarity NPD4749 Approved
0.6438 Remote Similarity NPD5327 Phase 3
0.6434 Remote Similarity NPD1432 Clinical (unspecified phase)
0.6429 Remote Similarity NPD4108 Discontinued
0.6429 Remote Similarity NPD7033 Discontinued
0.642 Remote Similarity NPD8055 Clinical (unspecified phase)
0.6416 Remote Similarity NPD6797 Phase 2
0.6391 Remote Similarity NPD940 Approved
0.6391 Remote Similarity NPD3787 Discontinued
0.6391 Remote Similarity NPD846 Approved
0.6382 Remote Similarity NPD4060 Phase 1
0.638 Remote Similarity NPD7028 Phase 2
0.6379 Remote Similarity NPD6559 Discontinued
0.6379 Remote Similarity NPD7251 Discontinued
0.6358 Remote Similarity NPD7074 Phase 3
0.6351 Remote Similarity NPD4104 Clinical (unspecified phase)
0.6351 Remote Similarity NPD4103 Phase 2
0.6346 Remote Similarity NPD2029 Clinical (unspecified phase)
0.6343 Remote Similarity NPD7808 Phase 3
0.6343 Remote Similarity NPD4338 Clinical (unspecified phase)
0.6343 Remote Similarity NPD5765 Approved
0.634 Remote Similarity NPD4340 Discontinued
0.6331 Remote Similarity NPD6912 Phase 3
0.6331 Remote Similarity NPD228 Approved
0.6329 Remote Similarity NPD4628 Phase 3
0.6327 Remote Similarity NPD4659 Approved
0.6327 Remote Similarity NPD3685 Discontinued
0.6324 Remote Similarity NPD968 Approved
0.6316 Remote Similarity NPD6233 Phase 2
0.6312 Remote Similarity NPD6143 Clinical (unspecified phase)
0.6306 Remote Similarity NPD2424 Discontinued
0.6304 Remote Similarity NPD4750 Phase 3
0.6304 Remote Similarity NPD9380 Clinical (unspecified phase)
0.6286 Remote Similarity NPD7240 Approved
0.6276 Remote Similarity NPD9381 Approved
0.6276 Remote Similarity NPD9384 Approved
0.6276 Remote Similarity NPD3019 Approved
0.6276 Remote Similarity NPD2932 Approved
0.6276 Remote Similarity NPD5846 Approved
0.6276 Remote Similarity NPD6516 Phase 2
0.6275 Remote Similarity NPD2238 Phase 2
0.6273 Remote Similarity NPD7004 Clinical (unspecified phase)
0.6268 Remote Similarity NPD6671 Approved
0.6265 Remote Similarity NPD2977 Approved
0.6265 Remote Similarity NPD2978 Approved
0.625 Remote Similarity NPD3122 Phase 3
0.625 Remote Similarity NPD3764 Approved
0.6243 Remote Similarity NPD3751 Discontinued
0.6242 Remote Similarity NPD1375 Discontinued
0.6241 Remote Similarity NPD2228 Approved
0.6241 Remote Similarity NPD2229 Approved
0.6241 Remote Similarity NPD2234 Approved
0.6241 Remote Similarity NPD5283 Phase 1
0.624 Remote Similarity NPD111 Approved
0.6218 Remote Similarity NPD7743 Approved
0.6218 Remote Similarity NPD7742 Approved
0.6215 Remote Similarity NPD8312 Approved
0.6215 Remote Similarity NPD8313 Approved
0.6209 Remote Similarity NPD6405 Approved
0.6209 Remote Similarity NPD6407 Approved
0.619 Remote Similarity NPD5350 Clinical (unspecified phase)
0.619 Remote Similarity NPD422 Phase 1
0.619 Remote Similarity NPD5351 Clinical (unspecified phase)
0.6184 Remote Similarity NPD7095 Approved
0.6184 Remote Similarity NPD4625 Phase 3
0.6184 Remote Similarity NPD3180 Approved
0.6184 Remote Similarity NPD3179 Approved
0.6173 Remote Similarity NPD8389 Clinical (unspecified phase)
0.6173 Remote Similarity NPD4160 Clinical (unspecified phase)
0.6169 Remote Similarity NPD3062 Approved
0.6169 Remote Similarity NPD7966 Clinical (unspecified phase)
0.6169 Remote Similarity NPD3059 Approved
0.6169 Remote Similarity NPD3061 Approved
0.6159 Remote Similarity NPD6406 Approved
0.6159 Remote Similarity NPD1358 Approved
0.6149 Remote Similarity NPD2231 Phase 2
0.6149 Remote Similarity NPD2235 Phase 2
0.6149 Remote Similarity NPD7799 Discontinued
0.6144 Remote Similarity NPD6798 Discontinued
0.6143 Remote Similarity NPD9280 Clinical (unspecified phase)
0.614 Remote Similarity NPD8127 Discontinued
0.6138 Remote Similarity NPD9545 Approved
0.6135 Remote Similarity NPD7314 Clinical (unspecified phase)
0.6133 Remote Similarity NPD4339 Clinical (unspecified phase)
0.6129 Remote Similarity NPD3657 Discovery
0.6125 Remote Similarity NPD3892 Phase 2
0.6125 Remote Similarity NPD4535 Phase 3
0.6107 Remote Similarity NPD4379 Clinical (unspecified phase)
0.6107 Remote Similarity NPD845 Approved
0.6107 Remote Similarity NPD2982 Phase 2
0.6107 Remote Similarity NPD9622 Approved
0.6107 Remote Similarity NPD3600 Clinical (unspecified phase)
0.6107 Remote Similarity NPD2983 Phase 2
0.6101 Remote Similarity NPD5958 Discontinued
0.6095 Remote Similarity NPD4868 Clinical (unspecified phase)
0.6093 Remote Similarity NPD6917 Clinical (unspecified phase)
0.609 Remote Similarity NPD5314 Approved
0.609 Remote Similarity NPD288 Approved
0.6087 Remote Similarity NPD2677 Approved
0.6087 Remote Similarity NPD3134 Approved
0.6074 Remote Similarity NPD289 Clinical (unspecified phase)
0.6074 Remote Similarity NPD3028 Approved
0.6069 Remote Similarity NPD16 Approved
0.6069 Remote Similarity NPD856 Approved
0.6066 Remote Similarity NPD7879 Clinical (unspecified phase)
0.6065 Remote Similarity NPD5837 Clinical (unspecified phase)
0.6062 Remote Similarity NPD4237 Approved
0.6062 Remote Similarity NPD4236 Phase 3
0.6059 Remote Similarity NPD7975 Clinical (unspecified phase)

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data